SCYX - Kapitalisasi marang volume dodolan SCYNEXIS Inc

Logo korporat perusahaan SCYNEXIS, Inc. (SCYX)

SCYNEXIS, Inc. (SCYX) develops innovative antimycotics, leveraging its partnership with GSK and expansion within hospitals. On GURU.Markets, the price-to-sales ratio exhibits volatility, with the latest value recorded as 1.80. While stock options help retain a strong scientific team, the high burn rate and dependence on R&D trials create significant financial risks for the business.

SCYNEXIS, Inc. (SCYX): Rasio rega marang pendapatan saka 04.07.2022 nganti 13.11.2026

Rincian metrik lan analitis perusahaan SCYNEXIS, Inc. (SCYX)

- rega pasar lan target rega analis:
Kutipan saham scynexis.com|SCYX - Target konsensus
- statistik kapitalisasi pasar:
Nilai pasar Scynexis|SCYX - Nilai Perusahaan
- informasi kapitalisasi buku:
Aset Bersih saben Saham SCYNEXIS|SCYX - Nilai Buku Perusahaan|Koefisien Nilai Pasar marang Nilai Buku scynexis.com|SCYX - Aset Agregat Perusahaan
- statistik kawajiban utang lan likuiditas:
Rasio Utang marang Ekuitas SCYNEXIS, Inc.|SCYX - Utang jangka dawa marang ekuitas|Koefisien utang jangka cendhak marang modal scynexis.com|SCYX - Utang perusahaan|Utang-utang marang aset resik Scynexis|SCYX - Utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan SCYNEXIS|Likuiditas darurat scynexis.com
- data bathi resik lan rasio valuasi:
SCYX - Bathi resik perusahaan|Prakiraan bathi resik SCYNEXIS, Inc.|SCYX - Pangali P/E|Rasio prakiraan rega marang bathi scynexis.com|SCYX - Pangali rega marang bathi tumrap wutah|Nilai perusahaan marang bathi operasional sadurunge panyusutan Scynexis|SCYX - Bathi operasional EBITDA|Bathi resik saben saham sajrone patang kuartal pungkasan SCYNEXIS|SCYX - Bathi saben saham sajrone rolas wulan pungkasan|Owah-owahan bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan scynexis.com|SCYX - Wutah bathi resik saben saham ing taun iki|Dinamika bathi saben saham sing diarepake ing taun ngarep SCYNEXIS, Inc.
- data total pendapatan lan volume dodolan:
SCYX - Pendapatan lan volume dodolan|Dodolan mangsa ngarep perusahaan scynexis.com|SCYX - Rasio rega marang pendapatan|Kapitalisasi marang prakiraan pendapatan Scynexis
Analisis fundamental perusahaan:SCYX, SCYNEXIS Inc
Produk sing diprodhuksi SCYNEXIS Inc

The P/S ratio determines the market value of a business relative to its annual revenue, measuring the premium investors are willing to pay per unit of sales. The P/S ratio dynamics for SCYNEXIS, Inc. (SCYX) reflect the impact of the global antifungal distribution partnership on the company's capitalization. The expansion of clinical indications for its drugs directly scales cash flow, adjusting the fundamental valuation of the asset. A stable trend for this indicator minimizes the risk of overpaying for future growth.

Perusahaan pesaing

Kapitalisasi marang pendapatan summittxinc.com SMMT|Moderna - Kapitalisasi marang pendapatan|Kapitalisasi marang volume dodolan PCVX (Vaxcyte Inc)|Tarsus Pharma - Multiplikator P/S|Koefisien rega marang pendapatan CorMedix Therapeutics CRMD|Seres Therapeutics (MCRB) - Rasio rega marang pendapatan|Rega marang dodolan sperotherapeutics.com (SPRO)|Rasio rega marang pendapatan AN2 Therapeutics Inc|Rasio kapitalisasi marang pendapatan PYPD (PolyPid Limited)|Rasio rega marang pendapatan YS Biopharma (LSB)|Koefisien rega marang pendapatan iterumtx.com|Rasio rega marang pendapatan BiomX PHGE|Koefisien rega marang pendapatan Soligenix Inc (SNGX)|60 Degrees Pharma - Multiplikator P/S|oragenics.com (OGEN) - Kapitalisasi marang pendapatan|OPGN (OpGen Corp) - Kapitalisasi marang pendapatan